Revenues of MADRIGAL PHARMACEUTICALS, INC. from 31 Dec 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
MADRIGAL PHARMACEUTICALS, INC. quarterly and annual Revenues in USD history and change rate from 31 Dec 2012 to 31 Mar 2025.
  • MADRIGAL PHARMACEUTICALS, INC. Revenues for the quarter ending 31 Mar 2025 was $137,250,000.
  • MADRIGAL PHARMACEUTICALS, INC. annual Revenues for 2024 was $180,133,000.
  • MADRIGAL PHARMACEUTICALS, INC. annual Revenues for 2023 was $0.
  • MADRIGAL PHARMACEUTICALS, INC. annual Revenues for 2022 was $0.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, Annual (USD)

MADRIGAL PHARMACEUTICALS, INC. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $137,250,000 +$137,250,000 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $0 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $0 $0 $0 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
Q3 2023 $0 $0 $0 01 Jul 2023 30 Sep 2023 10-K 28 Feb 2024 2023 FY
Q2 2023 $0 $0 $0 01 Apr 2023 30 Jun 2023 10-K 28 Feb 2024 2023 FY
Q1 2023 $0 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $0 $0 $0 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $0 $0 $0 01 Jul 2022 30 Sep 2022 10-K 28 Feb 2024 2023 FY
Q2 2022 $0 $0 $0 01 Apr 2022 30 Jun 2022 10-K 28 Feb 2024 2023 FY
Q1 2022 $0 $0 $0 01 Jan 2022 31 Mar 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $0 $0 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $0 $0 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $0 $0 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $0 01 Jan 2021 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 $0 $0 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $0 $0 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q3 2019 $0 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $0 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2

MADRIGAL PHARMACEUTICALS, INC. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $180,133,000 +$180,133,000 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
2023 $0 $0 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
2022 $0 $0 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $0 $0 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
2019 $0 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2012 $147,000 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.